Yong G Peng

Dr. Yong G Peng

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 November 2021 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
PDF file
HLHua Liu
Hua Liu
TJT. Everett Jones
T. Everett Jones
EJEric Jeng
Eric Jeng
KPKevin L. Peng
Kevin L. Peng
YPYong G Peng
Yong G Peng

7 February 2025 in Clinical Transplantation
Verified
Journal Article
Closed access
BWBarbara Jeanne Wilkey
Barbara Jeanne Wilkey
TETyler Elliott
Tyler Elliott
TJTodd Everett Jones
Todd Everett Jones
TVTerrie Vasilopoulos
Terrie Vasilopoulos
TGTheresa Gelzinis
Theresa Gelzinis
AMArcher Kilbourne Martin
Archer Kilbourne Martin

9 October 2020 in Medicine
Verified
Journal Article
Open access
YMYang Meng-Chang
Yang Meng-Chang
WMWu Meng-Jun
Wu Meng-Jun
XXXu Xiao-Yan
Xu Xiao-Yan
KPKevin L. Peng
Kevin L. Peng
YPYong G Peng
Yong G Peng
RWRurong Wang
Rurong Wang
Objective: This meta-analysis aimed to review the available evidence and evaluate the necessity of immediate coronary angiography (CAG) to obtain positive outcomes for out-of-hospital cardiac arrest (OHCA) patients without ST segment elevation. Data sources: Web of Science, PubMed, Embase, Chinese National Knowledge Infrastructure, Wanfang, and SinoMed databases. Study selection: We included observational and case–control studies of outcomes among individuals without ST segment elevation experiencing OHCA who had immediate, delayed, or no CAG. Data extraction: We extracted study details, as well as patient characteristics and outcomes. Data synthesis: Six studies (n = 2665) investigating mortality until discharge demonstrated a significant increase in survival benefit with early CAG (odds ratio [OR] = 1.78; 95%CI = 1.51–2.11; I2 = 81%; P < .0001). Seven studies (n = 2909) showed a significant preservation of neurological functions with early CAG at discharge (OR = 1.66; 95%CI = 1.37–2.02; P < .00001). Four studies (n = 1357) investigating survival outcomes with middle-term follow-up revealed no significant benefit with early CAG (OR = 1.21; 95%CI = 0.93–1.57; I2 = 66%; P = .15). Conclusions: Our meta-analysis demonstrates that there may be significant benefits in performing immediate CAG on patients who experience OHCA without ST segment elevation.

22 September 2010 in Journal of Artificial Organs
Verified
Journal Article
Closed access
PDF file
TCTheresa Crumpstone
Theresa Crumpstone
TMTomas D. Martin
Tomas D. Martin
JYJian J. Yang
Jian J. Yang
YPYong G Peng
Yong G Peng

2 February 2017 in BMC Anesthesiology
Verified
Journal Article
Open access
PDF file
BWBingjing Wu
Bingjing Wu
YPYong G Peng
Yong G Peng
SZShishi Zhao
Shishi Zhao
NBNana Bao
Nana Bao
LPLinmin Pan
Linmin Pan
QWQuanguang Wang
Quanguang Wang
Levosimendan exerted favorable effects on the initial outcome in the treatment of ventricular fibrillation cardiac arrest. This study investigated the efficacy of levosimendan in the treatment of asphyxia-induced cardiac arrest in rats. Animals underwent asphyxial cardiac arrest/cardiopulmonary resuscitation, randomized to three treatment groups: epinephrine (10 μg/kg) supplemented with levosimendan (bolus 12 μg/kg and infusion for 1 h, EL group); epinephrine only (10 μg/kg, E group), or levosimendan only (bolus 12 μg/kg and infusion for 1 h, L group). The resuscitation success rate, wet-to-dry ratio of lung, and rate of alveolar and blood gas analysis were recorded. 10 rats in the EL group, 8 in the E group, and 2 in the L group showed an initial return of spontaneous circulation (P < 0.001); among them, 10, 4, and 2 rats survived at the end of a 60-min observation period from each group, respectively (P = 0.001). The coronary perfusion pressure in the EL group was higher than that of either the E or L group (P < 0.05). The lung wet-to-dry weight ratio and rate of damaged alveoli were lower in the EL group than the E group (P < 0.05). In the early stage of resuscitation for asphyxia-induced cardiac arrest in rats, levosimendan supplemented with epinephrine can significantly increase coronary perfusion pressure, reduce lung injury, and ultimately enhance the survival rate.